| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.3 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |